Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix Read more about Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer Read more about Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer
TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary Read more about TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers Read more about Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer Read more about Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Read more about 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer Read more about Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer
Vaccine Therapy in Treating Patients With Metastatic Melanoma Read more about Vaccine Therapy in Treating Patients With Metastatic Melanoma
A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy Read more about A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia Read more about SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia